Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H12N2 |
| Molecular Weight | 100.1622 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCNCC1
InChI
InChIKey=PVOAHINGSUIXLS-UHFFFAOYSA-N
InChI=1S/C5H12N2/c1-7-4-2-6-3-5-7/h6H,2-5H2,1H3
| Molecular Formula | C5H12N2 |
| Molecular Weight | 100.1622 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Synthesis and pharmacological activity of amides and ozonolysis product of maleopimaric acid]. | 2011-02-15 |
|
| Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells. | 2010-11-15 |
|
| Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds. | 2010-09-15 |
|
| In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi. | 2010-09-14 |
|
| Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors. | 2010-09-09 |
|
| Chalcogenides of the aminomethylphosphines derived from 1-methylpiperazine, 1-ethylpiperazine and morpholine: NMR, DFT and structural studies for determination of electronic and steric properties of the phosphines. | 2010-08-28 |
|
| catena-Poly[(S)-2-methyl-piperazine-1,4-diium [[trichloridobismuthate(III)]-di-μ-chlorido]]. | 2010-08-11 |
|
| Determination of individual proton affinities of ofloxacin from its UV-Vis absorption, fluorescence and charge-transfer spectra: effect of inclusion in beta-cyclodextrin on the proton affinities. | 2010-08-05 |
|
| [Synthesis, modifications, and antimicrobial activity of the methylpiperazinyl amides of triterpenic acids]. | 2010-07-21 |
|
| Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei. | 2010-06-08 |
|
| A statistics-based platform for quantitative N-terminome analysis and identification of protease cleavage products. | 2010-05 |
|
| Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using AKTAxpress. | 2010-05 |
|
| Synthesis and antimicrobial activities of some new 1,2,3-triazole derivatives. | 2010-04-08 |
|
| Conjugate addition of nucleophiles to the vinyl function of 2-chloro-4-vinylpyrimidine derivatives. | 2010-03-19 |
|
| Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. | 2010-02 |
|
| Detection of nitric oxide in tissue samples by ESI-MS. | 2010-02 |
|
| Synthesis and biological evaluation of N-hydroxyphenylacrylamides and N-hydroxypyridin-2-ylacrylamides as novel histone deacetylase inhibitors. | 2010-01-28 |
|
| Imatinibium dipicrate. | 2010-01-20 |
|
| Theoretical and experimental studies of the isomeric protonation in solution for a prototype aliphatic ring containing two nitrogens. | 2010-01-14 |
|
| Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors. | 2010-01 |
|
| Solution structure of a covalently bound pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole hybrid to a 10mer DNA duplex. | 2009-12-29 |
|
| Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. | 2009-12-08 |
|
| [2-(4-Methyl-piperazin-1-ylmeth-yl)phen-yl]diphenyl-phosphane. | 2009-11-25 |
|
| Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. | 2009-09-30 |
|
| Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. | 2009-09-21 |
|
| Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety. | 2009-09 |
|
| Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities. | 2009-07 |
|
| Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay. | 2009-05-15 |
|
| Manipulation of fluorescent and colorimetric changes of fluorescein derivatives and applications for sensing silver ions. | 2009-03-14 |
|
| Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities. | 2009-03 |
|
| The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2). | 2009-02-24 |
|
| Development and targeted use of nilotinib in chronic myeloid leukemia. | 2009-02-06 |
|
| Synthesis and spectral characterization of a new class of N-(N-methylpiperazinoacetyl)-2,6-diarylpiperidin-4-ones: antimicrobial, analgesic and antipyretic studies. | 2009-02 |
|
| Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs. | 2009-01-15 |
|
| Hoechst 33342: the dye that enabled differentiation of living X-and Y-chromosome bearing mammalian sperm. | 2009-01-01 |
|
| The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. | 2009 |
|
| Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. | 2008-10-23 |
|
| Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation. | 2008-10-13 |
|
| Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib. | 2008-10-01 |
|
| Copper(I) cyanide networks: synthesis, structure, and luminescence behavior. Part 2. Piperazine ligands and hexamethylenetetramine. | 2008-08-04 |
|
| Use of N-methylpiperazine for the preparation of piperazine-based unsymmetrical bis-ureas as anti-HIV agents. | 2008-07 |
|
| Determination of analogs of sildenafil and vardenafil in foods by column liquid chromatography with a photodiode array detector, mass spectrometry, and nuclear magnetic resonance spectrometry. | 2008-06-24 |
|
| Morpholine-based immonium and halogenoamidinium salts as coupling reagents in Peptide synthesis1. | 2008-04-04 |
|
| 3-(4-Methyl-piperazin-1-yl)isobenzofuran-1(3H)-one. | 2008-04-02 |
|
| Synthesis and Pharmacological Evaluation of (6-Substituted 4-Oxo-4H-chromene-3 yl) methyl N-substituted Aminoacetates. | 2008-01 |
|
| Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. | 2008 |
|
| N-Methyl-piperazinediium penta-chloridoanti-monate(III) monohydrate. | 2007-12-12 |
|
| NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor. | 2007-11-14 |
|
| Synthesis of o-sulfamidotriazobenzenes from 1,1'-sulfonylbis(benzotriazole). | 2007-07-20 |
|
| Precise protein quantification based on peptide quantification using iTRAQ. | 2007-06-21 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:36:17 GMT 2025
by
admin
on
Mon Mar 31 19:36:17 GMT 2025
|
| Record UNII |
B92I95EL9Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Methylpiperazine
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
30195
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
53167
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
203-639-5
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
DTXSID4021898
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
1154015
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
30675
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
B92I95EL9Q
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
C048073
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY | |||
|
109-01-3
Created by
admin on Mon Mar 31 19:36:17 GMT 2025 , Edited by admin on Mon Mar 31 19:36:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (GC)
USP
|